296 related articles for article (PubMed ID: 33370605)
1. Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches.
Uddin MS; Mamun AA; Alghamdi BS; Tewari D; Jeandet P; Sarwar MS; Ashraf GM
Semin Cancer Biol; 2022 Aug; 83():100-120. PubMed ID: 33370605
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic pathways and glioblastoma treatment: insights from signaling cascades.
Allen BK; Stathias V; Maloof ME; Vidovic D; Winterbottom EF; Capobianco AJ; Clarke J; Schurer S; Robbins DJ; Ayad NG
J Cell Biochem; 2015 Mar; 116(3):351-63. PubMed ID: 25290986
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic modulation of metabolism in glioblastoma.
Dong Z; Cui H
Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma.
Wu Q; Berglund AE; Etame AB
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361090
[TBL] [Abstract][Full Text] [Related]
6. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
7. Zinc as a plausible epigenetic modulator of glioblastoma multiforme.
Balaji E V; Kumar N; Satarker S; Nampoothiri M
Eur J Pharmacol; 2020 Nov; 887():173549. PubMed ID: 32926916
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms in glioblastoma multiforme.
Nagarajan RP; Costello JF
Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
[TBL] [Abstract][Full Text] [Related]
10. Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics.
Chamarthy S; Mekala JR
Metab Brain Dis; 2023 Jun; 38(5):1441-1469. PubMed ID: 37093461
[TBL] [Abstract][Full Text] [Related]
11. An update on the epigenetics of glioblastomas.
Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
[TBL] [Abstract][Full Text] [Related]
12. Emerging Epigenetic Therapies for Brain Tumors.
Kukreja L; Li CJ; Ezhilan S; Iyer VR; Kuo JS
Neuromolecular Med; 2022 Mar; 24(1):41-49. PubMed ID: 34677796
[TBL] [Abstract][Full Text] [Related]
13. Regulatory networks driving expression of genes critical for glioblastoma are controlled by the transcription factor c-Jun and the pre-existing epigenetic modifications.
Roura AJ; Szadkowska P; Poleszak K; Dabrowski MJ; Ellert-Miklaszewska A; Wojnicki K; Ciechomska IA; Stepniak K; Kaminska B; Wojtas B
Clin Epigenetics; 2023 Feb; 15(1):29. PubMed ID: 36850002
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity.
Asuthkar S; Velpula KK; Chetty C; Gorantla B; Rao JS
Oncotarget; 2012 Nov; 3(11):1439-54. PubMed ID: 23183822
[TBL] [Abstract][Full Text] [Related]
15. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells.
Reddy RG; Bhat UA; Chakravarty S; Kumar A
Cancer Chemother Pharmacol; 2020 Aug; 86(2):165-179. PubMed ID: 32638092
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Mechanisms Histone Deacetylase-Dependent Regulate the Glioblastoma Angiogenic Matrisome and Disrupt Endothelial Cell Behavior In Vitro.
Menezes A; Julião G; Mariath F; Ferreira AL; Oliveira-Nunes MC; Gallucci L; Evaristo JAM; Nogueira FCS; Pereira DA; Carneiro K
Mol Cell Proteomics; 2024 Mar; 23(3):100722. PubMed ID: 38272115
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic approaches in glioblastoma multiforme and their implication in screening and diagnosis.
Hyman G; Manglik V; Rousch JM; Verma M; Kinkebiel D; Banerjee HN
Methods Mol Biol; 2015; 1238():511-21. PubMed ID: 25421677
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
Ghasemi A; Fallah S; Ansari M
Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
[TBL] [Abstract][Full Text] [Related]
19. Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue.
Luo K; Luo D; Wen H
Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27160082
[TBL] [Abstract][Full Text] [Related]
20. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
